Relationship between gastric cancer Tau protein expression and paclitaxel sensitivity

Pathology and Oncology Research

Volumn 19, Issue 3, 2013, Pages 429-435

  Wang, Qiong ^a   Wang, Nanyao ^a   Shao, Guoyi ^a   Qian, Jianzhong ^a   Shen, Dong ^a   Fei, Yanhua ^a   Mao, Weidong ^a   Wu, Dan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Gastric cancer; Paclitaxel; Sensitivity; Tau protein

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT; PARAFFIN; TAU PROTEIN; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURGERY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING; ANALYSIS OF VARIANCE; BIOSYNTHESIS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PACLITAXEL; PARAFFIN EMBEDDING; STOMACH NEOPLASMS; TAU PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880331136     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9598-5     Document Type: Article

References (20)

1. Zheng LZ, Chen Q (2005) Gastric cancer chemotherapy status. Gastroenterology 10:178-181
2. Koizumi W (2005) Available options in chemotherapy for advanced gastric cancer: the current developments in Japan. Expert Opin Pharmacother 6:225-231
3. Scartozzi M, Galizia E, Verdecchia L, et al. (2007) Chemotherapy for advanced gastric cancer: across the years for a standard of care. Expert Opin Pharmaeother 8:797-808
4. Gu Y, Oyama F, Ihara Y, et al. (1996) Tau is widely expressed in rat tissues. J Neurochem 67:1235-1244
5. Shen ZL, Qu MH, He HJ, et al. (2008) HeLa, HEK293, SH-SY5Y, Tau protein in cells. Res Prog Biochem Biophys 35:1364-1370
6. Muszyńska-Roslan K, Krawczuk-Rybak M, Protas PT, et al. (2006) Level of Tau protein in children treated for acute lymphoblastic leukemia. Pediatr Neurol 34:367-371
7. Van CE, Moiseyenko VM, Tjulandin S, et al. (2006) Phase Ul study of docetaxel and eisplatin plus fluorouracil compared with eisphtin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group. J Clin Oncol 24:4991-4997
8. Yan S (2006) Antitumor handbook. Beijing: Peking University Medical Press 11:178
9. Wang F, Han R (2002) Development of research for drug-resistance mechanism of taxol. Ai Zheng 21:439-442
10. Li Z, Wang LM, Geng MY (2006) Tau protein and nerve cell death. Chin Clinical Rehabilitation 10:124-126
11. Rossi G, Dalpra L, Crosti F, et al. (2008) A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle 7:1788-1794
12. Pentheroudakis G, Kalogeras KT, Wirtz RM, et al. (2009) Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Breast Cancer Res Treat 116:131-143
13. Pusztai L, Jeong JH, Gong Y, et al. (2009) Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. J Clin Oncol 10:4287-4292
14. Andre F, Hatzis C, Anderson K, et al. (2007) Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. Clin Cancer Res 13:2061-2067
15. Wagner P, Wang B, Clark E, et al. (2005) Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 4:1149-1152
16. Rouzier R, Rajan R, Wagner P, et al. (2005) Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA 102:8315-8320
17. Chambonniere ML, Mosnier-Damet M, Mosnier JF, et al. (2001) Expression of microtubule-associated protein tau by gastrointestinal stromal tumors. Hum Pathol 32:1166-1173
18. Mimori K, Sadanaga N, Yoshikawa Y, et al. (2006) Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. Br J Cancer 94:1894-1897
19. Feng R, Bao YZ, Peng CW, et al. (2010) Tau gene expression and sensitivity of gastric cancer in paclitaxel treatment. Theory Pract Surg 15:432-437
20. Qiu LX, Qian XP, Liu B (2009) Research progress on Taxane drug efficacy forecast molecular. Modern Oncol 17:1583-1584